Bliss GVS Pharma Limited has informed the Exchange regarding allotment of 38000 securities pursuant to ESOP/ESPS at its meeting held on August 29, 2025
BLISSGVS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Bliss GVS Pharma has allotted 38,000 equity shares of Re. 1 each to eligible employees who exercised their stock options under the Bliss GVS ESOP-2019 scheme on August 29, 2025. The exercise price was Rs. 43 per share, with a premium of Rs. 42 per share. Following this allotment, the total paid-up share capital has increased from 10,55,71,523 to 10,56,09,522 equity shares, a marginal rise of about 0.004%. The new shares will carry a 6-month lock-in period expiring February 28, 2026, after which they will rank equally with existing shares. Listing fees are not applicable as the shares are already listed on BSE and NSE.
This is a routine ESOP allotment with negligible dilution (less than 0.01%) and no material impact on share price. Existing shareholders may see a very slight reduction in their percentage stake, but it is not significant. Investors should note the lock-in expiry date of February 28, 2026, after which these shares become freely tradable.